Trajenta Header Menu

Trajenta®

(Linagliptin)

Watch. Download. Learn.

We appreciate that you have taken the time to learn more about Trajenta®. That is why we have collected a variety of resources related to Trajenta® and how its Simplicity can help you in your daily management of type 2 diabetes patients. Continue below or use the quick links right hand side to find the right resource.

Patient Profile

Simplicity for a broad range of T2D patients

Patients of Asian subgroup have shown safety and efficacy in reducing HbA1c with the simple, single dose of Trajenta

MYRA: 44 Years

Newly diagnosed T2D

Patients of Asian subgroup have shown safety and efficacy in reducing HbA1c with the simple, single dose of Trajenta

SAPNA:  55 Years

Early kidney disease

Patients of Asian subgroup have shown safety and efficacy in reducing HbA1c with the simple, single dose of Trajenta

SATISH: 58 Years

Established CVD

Patients of Asian subgroup have shown safety and efficacy in reducing HbA1c with the simple, single dose of Trajenta

JAGDISH: 64 Years

Moderate kidney disease
& heart failure

Patients of Asian subgroup have shown safety and efficacy in reducing HbA1c with the simple, single dose of Trajenta

SARITA: 70 Years

Elderly with multiple comorbidities